In case the request is granted by Brazil’s drug regulator Anvisa, Coronavac may be the first vaccine against coronavirus authorized for children from 3 years onwards.
The vaccine includes ButanVac - an immunizer produced by Butantan, which is being evaluated in clinical trials, and the influenza vaccine, also produced by the institute.
Study found 99% of vaccinated people in Serrana seroconverted.The indicator was higher than the results from the clinical trials from phases one and two of CoronaVac, showing seroconversion at around 97 and 98 percent, respectively, depending on the dose.
ButanVac will be produced at the Butantan factory where flu vaccines are made—a production that has already come to an end this year. ButanVac will be fully manufactured in São Paulo, with no imported supplies necessary.